Sage Journals: Discover world-class research

Open access

Case report

First published 2025

Refractory erythroderma in idiopathic hypereosinophilic syndrome: A case treated with mepolizumab and abrocitinib

Hiba Elhaj, Ahmad Al Amari, Fatemah Alyaqout [...]

Sage Open Medical Case Reports

Open access

Research article

First published 2020

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy

Giovanna Elisiana Carpagnano, Corrado Pelaia, Maria D’Amato [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Review article

First published 2026

Efficacy and Safety of Mepolizumab in Eosinophilic COPD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Rahul Bisht, Arusha Desai, Esteban Marcelo Mogrovejo Carrión [...]

Annals of Pharmacotherapy

Free access

Review article

First published 2016-11

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential

Francesco Menzella, Mirco Lusuardi, Carla Galeone [...]

Sage Open Chronic Disease

Open access

Review article

First published 2018-10

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience

Rosalia Emma, Jaymin B. Morjaria, Virginia Fuochi [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2021-3

Subcutaneous Mepolizumab Injection: An Adjunctive Treatment for Recalcitrant Allergic Fungal Rhinosinusitis Patients With Asthma

John Karp, India Dhillon, Rikesh Panchmatia [...]

American Journal of Rhinology & Allergy

Open access

Research article

First published 2021

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study

Aikaterini Detoraki, Eugenio Tremante, Maria D’Amato [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2022

Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies

Thomas B. Casale, Autumn Burnette, Arnaud Bourdin [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2026

Mepolizumab for eosinophilic COPD with frequent exacerbations: single-centre real-world experience in a phenotype-directed approach

Irena Šarc, Tina Morgan, Igor Požek [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2016-03

Mepolizumab: A New Class of Treatment for Adolescents with Severe Persistent Asthma

Kathryn Blake, Hengameh Raissy

Pediatric Allergy,Immunology,and Pulmonology

Search results